1. Home
  2. ELTX vs STEX Comparison

ELTX vs STEX Comparison

Compare ELTX & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • STEX
  • Stock Information
  • Founded
  • ELTX 2011
  • STEX 2009
  • Country
  • ELTX United States
  • STEX United States
  • Employees
  • ELTX N/A
  • STEX N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • STEX
  • Sector
  • ELTX Health Care
  • STEX
  • Exchange
  • ELTX Nasdaq
  • STEX Nasdaq
  • Market Cap
  • ELTX 158.5M
  • STEX 172.1M
  • IPO Year
  • ELTX N/A
  • STEX N/A
  • Fundamental
  • Price
  • ELTX $9.15
  • STEX $4.48
  • Analyst Decision
  • ELTX Strong Buy
  • STEX Strong Buy
  • Analyst Count
  • ELTX 1
  • STEX 1
  • Target Price
  • ELTX $13.00
  • STEX $12.00
  • AVG Volume (30 Days)
  • ELTX 110.4K
  • STEX 754.8K
  • Earning Date
  • ELTX 11-13-2025
  • STEX 11-14-2025
  • Dividend Yield
  • ELTX N/A
  • STEX N/A
  • EPS Growth
  • ELTX N/A
  • STEX N/A
  • EPS
  • ELTX N/A
  • STEX N/A
  • Revenue
  • ELTX N/A
  • STEX $13,000.00
  • Revenue This Year
  • ELTX N/A
  • STEX N/A
  • Revenue Next Year
  • ELTX N/A
  • STEX N/A
  • P/E Ratio
  • ELTX N/A
  • STEX N/A
  • Revenue Growth
  • ELTX N/A
  • STEX N/A
  • 52 Week Low
  • ELTX $4.60
  • STEX $0.40
  • 52 Week High
  • ELTX $12.62
  • STEX $14.11
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 51.67
  • STEX N/A
  • Support Level
  • ELTX $7.87
  • STEX N/A
  • Resistance Level
  • ELTX $8.99
  • STEX N/A
  • Average True Range (ATR)
  • ELTX 0.53
  • STEX 0.00
  • MACD
  • ELTX 0.08
  • STEX 0.00
  • Stochastic Oscillator
  • ELTX 82.72
  • STEX 0.00

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About STEX Streamex Corp. Common Stock

Streamex Corp is a Real World Asset (RWA) tokenization company with Institutional grade infrastructure to bring the gold and commodities market on chain. Enabled by a gold denominated treasury and tokenization technology powering the modern commodities market.

Share on Social Networks: